# VAREX TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE - Varex Imaging
Canonical URL: https://biopharmsignal.com/news/VREX/varex-to-present-at-the-jefferies-global-healthcare-conference-varex-imaging-7485a79a
Ticker: VREX
Company: Varex Imaging
Source: Varex Imaging
Published: 2026-07-09 15:15 EST
Original Source URL: https://www.vareximaging.com/news/
## Summary

SALT LAKE CITY, May 28, 2026 – Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management will participate in a fireside chat presentation on Wednesday, June 3, 2026 at 3:10 pm ET. The presentation will be webcast and can be accessed […]

## Article Body
SALT LAKE CITY, May 28, 2026 – Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York.

Management will participate in a fireside chat presentation on Wednesday, June 3, 2026 at 3:10 pm ET. The presentation will be webcast and can be accessed here or on Varex’s website at www.vareximaging.com/news .

About Varex

Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems, as well as X-ray imaging systems for industrial applications. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices, and imaging software in their systems to detect, diagnose, protect, and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,450 people located in North America, Europe, and Asia. For more information visit vareximaging.com.

For Information Contact:

Sam Maheshwari

Chief Financial Officer

Varex Imaging Corporation

801.973.1574 | investors@vareximaging.com
## Recent Company News
- 2026-07-09 15:15 EST — [VAREX TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE - Varex Imaging](https://biopharmsignal.com/news/VREX/varex-to-present-at-the-jefferies-global-healthcare-conference-varex-imaging-7485a79a) — Source: Varex Imaging
- 2026-07-08 16:03 EST — [The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging - Varex Imaging](https://biopharmsignal.com/news/VREX/the-gigact-advancing-photon-counting-ct-for-next-generation-spectral-imaging-var-753f47a9) — Source: Varex Imaging
- 2026-07-07 17:53 EST — [White Paper: Pyxis™ Photon-Counting CT Detection Platform – Simplifying the Integration of Photon-Counting Computed Tomography - Varex Imaging](https://biopharmsignal.com/news/VREX/white-paper-pyxis-photon-counting-ct-detection-platform-simplifying-the-integrat-9b2cc7b7) — Source: Varex Imaging
- 2026-07-07 17:49 EST — [Replacing Mechanical Motion in X-ray Imaging: Varex Multi-Beam X-ray (MBX) Technology - Varex Imaging](https://biopharmsignal.com/news/VREX/replacing-mechanical-motion-in-x-ray-imaging-varex-multi-beam-x-ray-mbx-technolo-15a26bbf) — Source: Varex Imaging
- 2026-06-29 18:05 EST — [Tackling CT artifacts in multi-material parts: TrueSpectrum™ at ECNDT 2026 - Varex Imaging](https://biopharmsignal.com/news/VREX/tackling-ct-artifacts-in-multi-material-parts-truespectrum-at-ecndt-2026-varex-i-b14701de) — Source: Varex Imaging
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)